AWA
GH icon

Arkadios Wealth Advisors’s Guardant Health GH Stock Holding History

Arkadios Wealth Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-65
Closed -$8K – 1044
2021
Q3 		$8K Hold
65
– – ﹤0.01% 1495
2021
Q2 		$8K Buy
+65
New +$8.74K ﹤0.01% 1591
2020
Q4 		– Sell
-65
Closed -$6.57K – 1400
2020
Q3 		$6.57K Hold
65
– – ﹤0.01% 807
2020
Q2 		$5.27K Sell
65
-70
-52% -$5.64K ﹤0.01% 777
2020
Q1 		$9.4K Buy
+135
New +$10.4K 0.01% 652

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Arkadios Wealth Advisors's GH Position: Q4 2021 in Review

Arkadios Wealth Advisors sold out of Guardant Health (GH) in Q4 2021, closing a stake of 65 shares — an estimated $8K sold.

Arkadios Wealth Advisors first reported a position in GH in Q1 2020 and held it in 5 quarters. The position peaked at $9.4K in Q1 2020. 396 funds tracked by Wall St. Rank hold GH as of Q4 2021.

  • Arkadios Wealth Advisors reported no remaining Guardant Health position as of Q4 2021 after selling out during the quarter.
  • Arkadios Wealth Advisors sold 65 Guardant Health shares in Q4 2021, an estimated $8K.
  • Arkadios Wealth Advisors first reported a position in Guardant Health in Q1 2020 and held it in 5 quarters.
  • Arkadios Wealth Advisors's Guardant Health position peaked at $9.4K in Q1 2020.
  • 396 funds tracked by Wall St. Rank held Guardant Health as of Q4 2021.

Based on Arkadios Wealth Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.